Search / Trial NCT06230406

T-Mem GEne in Atherosclerosis

Launched by IRCCS POLICLINICO S. DONATO · Jan 19, 2024

Trial Information

Current as of October 07, 2024

Recruiting

Keywords

Description

The proposed study aims to analyze, in patients suffering from vascular pathologies, the modulation of the expression of the TMEM230 gene, identified in the laboratory of Dr. I. Zucchi of the Institute of Biomedical Technologies (CNR of Milan Segrate), and its role in the molecular mechanisms of atherosclerosis. This collaboration aims to collect a series of patients with different vascular pathologies. This is a transversal genetic study, which involves the analysis of approximately 12 samples of vascular tissue of various types coming from the intraoperative removal of material that is ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * adult patients (age \> 18 years)
  • * consent to participate in the study,
  • * patients coming to the Vascular Surgery Unit I of the IRCCS Policlinico San Donato for a vascular pathology of the arterial or venous district worthy of surgical treatment.
  • Exclusion Criteria:
  • * minor patients,
  • * patients who have not given their consent to participate in the study,
  • * patients who have vascular pathologies of the arterial or venous district not susceptible to surgical intervention.

About Irccs Policlinico S. Donato

IRCCS Policlinico S. Donato is a leading Italian research hospital and clinical trial sponsor dedicated to advancing medical science through innovative research and patient care. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it is recognized for its commitment to high-quality clinical research and the integration of scientific investigation with clinical practice. The institution specializes in various medical fields, including cardiology, oncology, and neurology, and collaborates with universities and research organizations to facilitate cutting-edge studies. With a focus on improving patient outcomes and contributing to public health, IRCCS Policlinico S. Donato plays a pivotal role in the development of new therapies and treatment protocols.

Locations

San Donato Milanese, Milan, Italy

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0